Join
Live feed
·
INSIDERFilingvia Quantisnow
Supernus Pharmaceuticals Inc. logo

Director Newhall Charles W Iii sold $45,000 worth of shares (1,000 units at $45.00), decreasing direct ownership by 0.74% to 133,232 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
SUPN· Supernus Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SUPN (Supernus Pharmaceuticals Inc.) and more on Quantisnow.